GranuFlo is the most widely prescribed dry acid product in the dialysis industry today. The company, Fresenius Medical Care, treats more than one-third of Americans receiving dialysis treatment. Patients who received treatment with GranuFlo and NaturaLyte have reported potentially fatal side effects such as heart attack or stroke. As a result, the FDA has issued a Class 1 GranuFlo and NaturaLyte recall based on the severity of these side effects.
The FDA’s warnings came after an internal memo was leaked from Fresenius Medical Care, alerting the FDA to the potentially dangerous and life-threatening side effects. In the memo, Fresenius reported that 941 patients had experienced sudden cardiac arrest after receiving treatment using GranuFlo and NaturaLyte. The manufacturer failed to share this information with thousands of physicians and clinics not owned by Fresenius Medical Care.
Types of Injuries and Serious Side Effects
GranuFlo and NaturaLyte side effects occur when the acid concentrates increase bicarbonate levels in the blood to dangerous levels during hemodialysis treatment. The heightened bicarbonate levels leave patients at risk for severe side effects. Dialysis patients have reported suffering serious problems including:
- Cardiac arrest
- Heart Attacks
- Sudden cardiac death
- Low blood pressure (hypotension)
- Myocardial infarction
Many of these problems were reported as occurring with 48 hours of dialysis treatment with GranuFlo or NaturaLyte.
Contact Us Today
If you or a loved one experienced a heart attack, stroke, or other side effects from hemodialysis treatment using GranuFlo or NaturaLyte, you may be eligible for compensation. To find out if you have the right to financial compensation for your pain and suffering, contact Principal Law Group today.